Skip to main content
Journal cover image

Heart Failure Collaboratory Statement on Clinical Trials in the Landscape of COVID-19.

Publication ,  Journal Article
Abraham, WT; Fiuzat, M; Psotka, MA; O'Connor, CM
Published in: JACC Heart Fail
May 2020

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

JACC Heart Fail

DOI

EISSN

2213-1787

Publication Date

May 2020

Volume

8

Issue

5

Start / End Page

423 / 425

Location

United States

Related Subject Headings

  • United States Food and Drug Administration
  • United States
  • Telemedicine
  • SARS-CoV-2
  • Practice Guidelines as Topic
  • Pneumonia, Viral
  • Pandemics
  • National Institutes of Health (U.S.)
  • Humans
  • Heart Failure
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Abraham, W. T., Fiuzat, M., Psotka, M. A., & O’Connor, C. M. (2020). Heart Failure Collaboratory Statement on Clinical Trials in the Landscape of COVID-19. JACC Heart Fail, 8(5), 423–425. https://doi.org/10.1016/j.jchf.2020.03.005
Abraham, William T., Mona Fiuzat, Mitchell A. Psotka, and Christopher M. O’Connor. “Heart Failure Collaboratory Statement on Clinical Trials in the Landscape of COVID-19.JACC Heart Fail 8, no. 5 (May 2020): 423–25. https://doi.org/10.1016/j.jchf.2020.03.005.
Abraham WT, Fiuzat M, Psotka MA, O’Connor CM. Heart Failure Collaboratory Statement on Clinical Trials in the Landscape of COVID-19. JACC Heart Fail. 2020 May;8(5):423–5.
Abraham, William T., et al. “Heart Failure Collaboratory Statement on Clinical Trials in the Landscape of COVID-19.JACC Heart Fail, vol. 8, no. 5, May 2020, pp. 423–25. Pubmed, doi:10.1016/j.jchf.2020.03.005.
Abraham WT, Fiuzat M, Psotka MA, O’Connor CM. Heart Failure Collaboratory Statement on Clinical Trials in the Landscape of COVID-19. JACC Heart Fail. 2020 May;8(5):423–425.
Journal cover image

Published In

JACC Heart Fail

DOI

EISSN

2213-1787

Publication Date

May 2020

Volume

8

Issue

5

Start / End Page

423 / 425

Location

United States

Related Subject Headings

  • United States Food and Drug Administration
  • United States
  • Telemedicine
  • SARS-CoV-2
  • Practice Guidelines as Topic
  • Pneumonia, Viral
  • Pandemics
  • National Institutes of Health (U.S.)
  • Humans
  • Heart Failure